Abbonarsi

Differential effects of post-dilation after stent deployment in patients presenting with and without acute myocardial infarction - 05/08/11

Doi : 10.1016/j.ahj.2010.07.007 
Zhi-Jiang Zhang, MD, PhD a, b, , Oscar C. Marroquin, MD b, c, Roslyn A. Stone, PhD d, Joel L. Weissfeld, MD, MPH b, Suresh R. Mulukutla, MD c, Faith Selzer, PhD b, Kevin E. Kip, PhD e
a Department of Epidemiology, School of Public Health, Shanghai Jiao Tong University, School of Medicine, Shanghai, China 
b Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA 
c Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 
d Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA 
e College of Nursing, University of South Florida, Tampa, FL 

Reprint requests: Zhi-Jiang Zhang, MD, PhD, 227 Chongqing South Road, Room 201, Building 1, Shanghai, China.

Riassunto

Background

In the practice of percutaneous coronary intervention, post-dilation often is performed after stent deployment to improve stent expansion. However, aggressive mechanical expansion is a risk factor of distal embolization and microvascular injury, especially for patients with acute myocardial infarction (AMI). Few studies have investigated the effects of post-dilation on medium-term clinical outcomes.

Methods and Results

Patients enrolled in the multicenter NHLBI Dynamic Registry between 2001 and 2006 were evaluated. Patients who were treated with ≥1 stent were studied. Patients with cardiogenic shock or history of coronary artery bypass graft surgery were excluded. Patients were followed up to 1 year. Because of the significant statistical interaction (P = .02) between post-dilation and AMI status on the hazard of death/myocardial infarction (MI), post-dilation effects were estimated separately for patients who did and did not present with an AMI. Among the 1,358 patients who presented with an AMI, post-dilation was associated with a significantly higher risk of death/MI (hazard ratio [HR] = 1.78, 95% CI 1.12-2.83, P = .01), not associated with the risk of repeat revascularization (HR = 1.15, 95% CI 0.81-1.62, P = .43). Among the 3,001 patients who did not present with AMI, post-dilation was not associated with risks of death/MI (HR = 1.08, 95% CI 0.77-1.50, P = .67) or repeat revascularization (HR = 1.17, 95% CI 0.93-1.47, P = .19). Similar effects were observed for the restricted analysis with additional adjustment for lesion characteristics among the 1,039 AMI patients and 2,179 non-AMI patients with a single lesion treated.

Conclusions

Stent post-dilation is associated with an increased risk of death/MI in AMI patients but not in non-AMI patients. Further investigation is warranted.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2010  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 160 - N° 5

P. 979 - novembre 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Long-term outcomes after drug-eluting stent for the treatment of ostial left anterior descending coronary artery lesions
  • Piera Capranzano, Alessandra Sanfilippo, Francesco Tagliareni, Davide Capodanno, Sergio Monaco, Gennaro Sardella, Arturo Giordano, Giuseppe M. Sangiorgi, Corrado Tamburino
| Articolo seguente Articolo seguente
  • Incidence and natural history of coronary artery aneurysm developing after drug-eluting stent implantation
  • Chul-Min Ahn, Bum-Kee Hong, Jong-Youn Kim, Pil-Ki Min, Young W. Yoon, Byoung K. Lee, Hyuck M. Kwon, Jung-Sun Kim, Young-Guk Ko, Donghoon Choi, Myeong-Ki Hong, Yangsoo Jang, Won-Heum Shim, Seung-Yun Cho, Byeong-Keuk Kim, Seongjin Oh, Dong W. Jeon, Joo Y. Yang, Jae-Hun Jung

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.